P.D. Hinduja Hospital & Medical Research Centre set to host conference on breast, lung and esophageal cancers

The overall objective of this conference is to increase awareness about new modalities in cancer care; discuss current challenges pertaining to different type of cancers and design appropriate solutions for better management of the disease and sharing knowledge and technology

P.D. Hinduja Hospital & Medical Research Centre set to host conference on breast, lung and esophageal cancersWith the number of cancer cases growing by the day, P.D. Hinduja Hospital & Medical Research Centre (MRC) has decided to organise a first-of-its-kind multi-disciplinary conference titled as ‘New Frontiers in Breast and Thoracic Malignancies’.

P.D. Hinduja Hospital & Medical Research Centre has jointly organized this conference with King’s College, London with an aim to address issues and the present day challenges in the management of breast, lung and esophageal cancers.

“The overall objective of this conference is to increase awareness about new modalities in cancer care; discuss current challenges pertaining to different type of cancers and design appropriate solutions for better management of the disease and sharing knowledge and technology. The ultimate aim of this conference is to give best medical service to our patients,” said Dr Murad E. Lala, Consultant Oncosurgeon, PD Hinduja Hospital, Mahim.

He added, “Incidents of cancer are increasing and most of them are lifestyle related, for example the consumption of tobacco products. A majority of patients seek medical help at third and fourth stages of cancer, which becomes difficult to treat. Early detection is very important to get cured from cancer. It will reduce the burden of the cancer treatment”.

Over 50 national and international experts will share their expertise and studies under one roof. It involves interactive sessions, case and panel discussions on breast cancer, lung cancer, esophagus cancer.

Dr Rucha Kaushik, Consultant Breast Surgeon at P.D. Hinduja Hospital, Mahim said, “This kind platform is very important to exchange knowledge. It will give a good learning experience to all the health experts as well medical students who are attending the conference”.

She also shared the current scenario of breast cancer in Mumbai, “Currently in every 32 cases we see one patient with breast cancer. Due to awareness among women we are getting early staged cancer cases, where the need for breast removal has reduced,” said Kaushik.

Some of the key topics to be discussed during this three day conference are emphasising on bridging the existing gaps in cancer care and management, to discuss global best practices and develop customised solutions for India, importance of early diagnosis, benefits of technological innovations and advancement in better patient outcomes, showcase global best practices in Cancer Management and Prevention, targeted Therapy for effective management of Lung, Breast and Esophageal cancers, cost impact of newer modalities and its relevance in India.

Dr Ganesh Nagarajan, Consultant – Gastroenterology Surgery, PD Hinduja Hospital, said “Esophageal cancer is growing because of habits, smoking, lifestyle related issues. Among the Esophageal cancer adenocarcinoma type is more due to obesity and other lifestyle habits. As we are moving fast towards westernisation it’s leading more number of esophageal cancers”.

Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus. The esophagus is a muscular tube that moves food and liquids from the throat to the stomach.

Under the esophagus cancer, the topics such as epidemiological trend of esophageal cancer in India and challenges in palliative care with esophageal cancer will be covered.

Under the breast cancer section, topics such as oncoplastic breast surgery, Westernisation – A cause for increase in breast cancer incidence in India and fertility issues in breast cancer will be discussed in detail.

Whereas under the Lung Cancer section, there will a discussion on recent advancements in Immunotherapy for lung cancer and minimal invasive surgery for lung cancer.

The three day conference started from Friday, April 22 will conclude on April 23.